Inhalis
Lugano, CH · 1 known investors
Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
Investors · 1
Frequently asked questions
- What does Inhalis do?
- Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.
- Who are Inhalis's investors?
- Inhalis's investors include TiVenture SA.
- Where is Inhalis headquartered?
- Inhalis is headquartered in Lugano, CH.